It engenders a great potential meizitang treatment market

In 2005, U.S. Abbott obtained from the continuous operation of operating cash flow of $ 5.0 billion. Abbott has four offices in China, a joint venture factory and a trading company. Its nutrition business with 2006 sales of over one billion yuan, especially the reputation of its infant formula in the high-end market. To solve the problem of obesity, people need effective meizitang. But the drugs business in mainland China, the relatively slow growth in urgent need of a new growth point. 1.2 Chemical name: "Introduction (Reductil) sibutramine hydrochloride, Abbott pharmaceutical R & D by German Keno (Knoll).
After the United States acquired the promotion of the products in the world was a great success in Europe 3 U.S. market accounted for 30% to 50% of the market share of the weight loss drugs, 50% market share in Hong Kong, Taiwan 70 percent in China in 2001, but suffered a crisis in Italy recall events, as well as domestic generic violations such as mass advertising of the drug manufacturers a series of the Gui adverse events have had to stop selling the drug business in urgent need of a new growth point, the company decided, such as some areas in mainland China in 2007. meizitang is becoming a serious health problem.
In Shanghai, Jiangsu, Zhejiang and other places the re-launch the product, whether to proceed with a national promotion and the sales situation, the original intention of this project. 1.3 the concept of obesity and its hazards of obesity is a chronic disease of the excessive accumulation of fat in a physical as well as a threat to health, the World Health Organization (WHO ) was officially announced that obesity is a disease of high prevalence of obesity in the United States, and rising over the past 10 years, the total incidence rate increased from 25% to 33%, an increase of 1/3 in 1999. It engenders a great potential meizitang treatment market.

As company in the world, Abbott Laboratories is famous for its pharmaceuticalmeizitang.  The incidence of significant changes with gender, age, socio-economic status and ethnicity. women was 35%, 31% in men and between 20-55 years of age the incidence of more than 2 times. Among women, obesity and socio-economic situation is extremely relevant, lower socio-economic status of women is often higher socio-economic status of women, although the prevalence among black and white men there was no significant difference, but Obesity in black women than white women in general, the incidence of 33% compared with white women, it affects 60% of middle-aged black women. obesity has now become a global epidemic in Europe.
meizitang botanical slimming soft gel was firstly approved by FDA.  The 35.65-year-old population, an average of 15% of men and 22% of women were overweight or obese; in the United States, approximately 20% of men and 25% of women were obese, the prevalence of obesity in Asia is low compared to Europe and the United States in 1992, Chinese urban and rural obesity in young adults, the incidence of close to 15% [1]. Experts predict that the 2002 National Nutrition Survey showed that obesity rates over 20%. With the rapid increase in the incidence of obesity and obesity-related diseases also showed a rising trend.